Yunfeng Capital and Hybio Acquire German Pharmaceutical Firm

For Digital Subscribers Only

A consortium led by Jack Ma-backed Yunfeng Capital and Shenzhen-listed Chinese biopharmaceutical company Hybio Pharmaceutical has entered into an agreement to buy all the shares of German speciality pharmaceutical firm AMW GmbH, according to the latter’s announcement.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

China Expert network

RELATED NEWS



LEAVE A REPLY